DNA molecules between telepathy
The latest study, DNA molecules appear to have telepathy. Scientists have discovered the double helix structure of DNA molecules to identify themselves with the "matching" elements, even some distance away, on the surface and no other outside help, the match of the two elements together to the end. In accordance with the previous understanding of DNA, scientists study the double helix structure of DNA molecules are arranged in accordance with the laws of their own. Helix structure of DNA molecule is composed of many ODN from the polymerization of long-chain, as the composition of the DNA base pairs of only four: adenine (A), guanine (G), cytosine (C) And thymine (T), therefore, there are four types of DNA, we usually A, T, C, G Four alphabet tag them, and use of chemical methods to match their children - A equipped with T, C equipped with G . In fact, the well-known "to exchange the role of the base together" is not the DNA double helix molecule in close connection with the bodies of the root causes. The DNA double helix structure was so stable, because the outside of deoxyribose phosphate and arranged in alternating the basic framework, the inside of the base to form hydrogen bonds through the base right. Scientists study the mixture through the fluorescence of this double-stranded DNA molecule structure. These DNA molecules were placed on some of the salt water, salt water test does not contain any proteins, DNA molecules will enable non-binding, as well as any material that may affect the trial. Strangely enough, together with the same number of base pairs of DNA molecules is the other remaining twice the number of DNA molecules. Even though they look like a very strange, like a psychological sense, but in fact only a DNA molecule in the exercise under the laws of physics, not a supernatural phenomenon. Take charge of deoxyribose and phosphate arranged in turn composed of DNA molecules will be mutually exclusive, however, because of the DNA double helix structure of the special, making the repulsive force between them to reach the minimum. In order to understand more vividly the researchers said, let us try the double helix structure of DNA molecules into a corkscrew imagination to form a long chain of DNA molecules in the base of support outside the framework and the role of hydrogen bonds in the middle of, So that the screw cone to the direction of a distorted, twisted into a spiral, then the process will be part of the same degree of bending and other elements of the sunken part of the coordinated combination. Scientists point out that this "psychological sense" would help the DNA molecules in the chaos of their pre-arranged neatly, which can effectively avoid errors occur when the combination of DNA, it effectively avoiding cancer, aging and other diseases. However, due to the same DNA sequence in fact disrupt the combination of sexual reproduction is a meaningful, because of the need to ensure that future generations have the genetic diversity.
Germ-line mutations, DNA damage, and global hypermethylation in mice exposed to particulate air pollution in an urban/industrial location
Environmental and Occupational Toxicology Division, HECSB, Ottawa, ON, Canada K1A 0K9; Department of Biology, McMaster University, 1280 Main Street West, Hamilton, ON, Canada L8S 4K1; ¶Nutrition and Toxicology Research Institute Maastricht, NUTRIM, Department of Health Risk Analysis and Toxicology, Maastricht University, 6200 MD, PO Box 616, Maastricht, The Netherlands; Division of Biochemical Toxicology, National Center for Toxicological Research, Jefferson, AR 72079; **Department of Biological Sciences, University of Lethbridge, 4401 University Drive, Lethbridge, Alta., Canada T1K 3M4; and Biostatistics and Epidemiology Division, Healthy Environments and Consumer Safety Branch, Ottawa, ON, Canada K1A 0K9
Edited by James E. Cleaver, University of California, San Francisco, CA, and approved November 20, 2007 (received for review June 25, 2007)
Particulate air pollution is widespread, yet we have little understanding of the long-term health implications associated with exposure. We investigated DNA damage, mutation, and methylation in gametes of male mice exposed to particulate air pollution in an industrial/urban environment. C57BL/CBA mice were exposed in situ to ambient air near two integrated steel mills and a major highway, alongside control mice breathing high-efficiency air particulate (HEPA) filtered ambient air. PCR analysis of an expanded simple tandem repeat (ESTR) locus revealed a 1.6-fold increase in sperm mutation frequency in mice exposed to ambient air for 10 wks, followed by a 6-wk break, compared with HEPA-filtered air, indicating that mutations were induced in spermatogonial stem cells. DNA collected after 3 or 10 wks of exposure did not exhibit increased mutation frequency. Bulky DNA adducts were below the detection threshold in testes samples, suggesting that DNA reactive chemicals do not reach the germ line and cause ESTR mutation. In contrast, DNA strand breaks were elevated at 3 and 10 wks, possibly resulting from oxidative stress arising from exposure to particles and associated airborne pollutants. Sperm DNA was hypermethylated in mice breathing ambient relative to HEPA-filtered air and this change persisted following removal from the environmental exposure. Increased germ-line DNA mutation frequencies may cause population-level changes in genetic composition and disease. Changes in methylation can have widespread repercussions for chromatin structure, gene expression and genome stability. Potential health effects warrant extensive further investigation.
Edited by James E. Cleaver, University of California, San Francisco, CA, and approved November 20, 2007 (received for review June 25, 2007)
Particulate air pollution is widespread, yet we have little understanding of the long-term health implications associated with exposure. We investigated DNA damage, mutation, and methylation in gametes of male mice exposed to particulate air pollution in an industrial/urban environment. C57BL/CBA mice were exposed in situ to ambient air near two integrated steel mills and a major highway, alongside control mice breathing high-efficiency air particulate (HEPA) filtered ambient air. PCR analysis of an expanded simple tandem repeat (ESTR) locus revealed a 1.6-fold increase in sperm mutation frequency in mice exposed to ambient air for 10 wks, followed by a 6-wk break, compared with HEPA-filtered air, indicating that mutations were induced in spermatogonial stem cells. DNA collected after 3 or 10 wks of exposure did not exhibit increased mutation frequency. Bulky DNA adducts were below the detection threshold in testes samples, suggesting that DNA reactive chemicals do not reach the germ line and cause ESTR mutation. In contrast, DNA strand breaks were elevated at 3 and 10 wks, possibly resulting from oxidative stress arising from exposure to particles and associated airborne pollutants. Sperm DNA was hypermethylated in mice breathing ambient relative to HEPA-filtered air and this change persisted following removal from the environmental exposure. Increased germ-line DNA mutation frequencies may cause population-level changes in genetic composition and disease. Changes in methylation can have widespread repercussions for chromatin structure, gene expression and genome stability. Potential health effects warrant extensive further investigation.
Direct Visualization of the EcoRII-DNA Triple Synaptic Complex by Atomic Force Microscopy
Interactions between distantly separated DNA regions mediated by specialized proteins lead to the formation of synaptic protein-DNA complexes. This is a ubiquitous phenomenon which is critical in various genetic processes. Although such interactions typically occur between two sites, interactions among three specific DNA regions have been identified, and a corresponding model has been proposed. Atomic force microscopy was used to test this model for the EcoRII restriction enzyme and provide direct visualization and characterization of synaptic protein-DNA complexes involving three DNA binding sites. The complex appeared in the images as a two-loop structure, and the length measurements proved the site specificity of the protein in the complex. The protein volume measurements showed that an EcoRII dimer is the core of the three-site synaptosome. Other complexes were identified and analyzed. The protein volume data showed that the dimeric form of the protein is responsible for the formation of other types of synaptic complexes as well. The applications of these results to the mechanisms of the protein-DNA interactions are discussed
DNA sequencing gels
Gels used for DNA sequence analysis are of the wedge type. These produce a voltage gradient which decreases as DNA migrates down the gel, thus retarding the rate of migration of smaller fragments and allowing more readable sequence information to be obtai ned from one gel. DNA sequencing gels are cast between the 38 x 50cm and 38 x 47.5cm glass plates of the Bio-Rad SequiGen?sequencing system.
You will need:
A standard detergent2% dichlorodimethyl silane in hexaneAbsolute ethanol6% sequencing acrylamide (5.7% acrylamide, 0.3% bisacrylamide, 48% urea, 1x TBE)25% AMPS (freshly made)TEMED
N.B: Wear gloves while handling solutions of unpolymerised acrylamide. Unpolymerised acrylamide is a neurotoxin.
1) Clean the glass plates extensively with detergent and water, tap water, distilled water and finally ethanol. Wipe dry with a clean paper towel.
2) Siliconize the smaller of the two plates using the 4% solution of dichlorodimethylsilane in hexane. The solution should be spread evenly over the plate and allowed to dry before being repeated. Once dry, the plate should be washed with 100% ethanol and again wiped dry using a clean paper towel.
3) Gel plates are then assembled as described in the manufacturers instructions using two 0.25 -1mm wedge spacers.
Polyacrylamide sequencing mix for use in the gels was stored at 4°C in a dark bottle.
4) 35ml of the acrylamide mix is used to first plug the bottom of the gel. Chill the acrylamide on ice and add 150ul 25% AMPS and 150ul TEMED. Mix by swirling and then poured briskly into the gel mould. The quantities of AMPS and TEMED may have to be esti mated empirically to cause setting in approx. 5 minutes.
5) Once the plug has set, 85ml of acrylamide is then used to form the main gel itself. To the acrylamide (chilled on ice beforehand), add 110ul 25% AMPS and 110ul TEMED. The solutions are mixed thoroughly, placed into a 50ml syringe and injected, carefull y, between the glass plates. In order to facilitate ease of pouring, the glass plates were inclined at an angle of approximately 10° to the horizontal in a large developing tray to prevent spills. Again, the quantities of AMPS and TEMED used may need to be varied in order to give polymerisation in approx. 30 minutes - this may be especially critical if the ambient temperature is abnormally warm.
N.B: It is critical to chill the acrylamide for the main gel in order to prevent polymerisation while the gel is being poured. You may also need to adjust the AMPS/TEMED quantities used. You should aim to have the plug set in ~5 mins and the main g el after ~30 mins.
6) Immediately after the gel is poured, a flat 0.25mm spacer (or reversed shark tooth comb) should be placed into the acrylamide on the gel top such that it intrudes into the gel by approximately 10mm. This allows the formation of a flat gel surface essen tial to the effective use of the shark tooth combs during electrophoresis. Clamp large bulldog clips across the top of the gel plates during gel polymerisation to ensure a leak-free fit of the combs. Allowed to polymerise for 1 hour at room temperature an d then use directly or store overnight at 4°C, tightly wrapped in clingfilm to prevent dehydration of the gel.
7) Remove the gel former and pre-electrophorese the gel at 1800V to heat the gel and running buffer to the required operating temperature (55°C) prior to the loading of the samples. Running buffer is 1 x TBE.
8) Insert sharks tooth combs such that the tips protrude approximately 0.5mm into the gel surface.
9) Thoroughly wash the wells immediately prior to the loading of the samples with running buffer to remove any urea which leaches from the gel.
10) Sequencing reaction mixtures, containing loading buffer, should be boiled for 2-3 minutes to denature any secondary structure and loaded into the wells (3ul/well), in the order G, A, T, C.
11) Electrophorese at 1800V (preferably 75W constant power) until the xylene cyanol dye front is approximately 5 cm from the bottom of the gel. Monitor the gel temperature to ensure it stays at 60°C or below (preferably 50-55°C).
N.B: Allowing the gel temperature to exceed 60°C for extended periods of time will cause the hydrolysis of urea in the gel.
12) After electrophoresis is complete, combs should be removed and the small siliconized glass plate gently removed from the remaining plate. The large plate, with the gel still attached, is then immersed in a fixative solution containing 10% acetic acid, 10% methanol for approximately 15-20 minutes. This process is used to remove urea from the gel.
13) Transfer the gel to a large sheet of Whatman 3MM paper and dry on a vacuum gel drier at 85°C for 75 minutes prior to autoradiography.
--------------------------------------------------------------------------------
Addendum submitted at 17:32 on 08/02/96 by: Dr. Simon Dawson,Department of Biochemistry,University of Nottingham,The Medical School,Q.M.C.,Clifton Boulevard,Nottingham,NG7 2UH,U.K.Tel: +44 115 9249924 Ex. 44787,FAX: +44 115 9422225,Email: Simon.Dawson@nott.ac.uk
This addendum describes the use of formamide in sequencing gels to alleviate problems with base stacking due to G-C compressions. The following method describes the production of 200ml of a 25% formamide, 6% acrylamide sequencing gel mix but it can be scaled accordingly. You can also vary the formamide concentration upto 40%.
You will need:
Ultra-pure ureaFormamideAcrylamideBis-acrylamideTEMEDAmmonium persulphate (AMPS)Amberlite MB-1 resin (Sigma)10 x TBE buffer
1) Mix together 82g urea, 50ml formamide, 11.4g acrylamide, 0.6g bis-acrylamide and ~60ml H2O.
2) Warm the mixture to ~40°C, with stirring, to dissolve solids.
N.B.: Do not heat the mixture above 55°C as this leads to hydrolysis of the urea.
3) Once dissolved, add ~5g Amberlite MB-1 resin and stir for 20 minutes.
4) Filter solution (we typically use Whatman 3MM paper) and make up to 180ml with H2O.
5) Add 20ml fresh 10 x TBE buffer.
6) For a gel of ~100ml, use 200ul TEMED and 200ul fresh 25% AMPS solution to initiate polymerisation.
N.B.: For the above quantities of TEMED and AMPS, you MUST chill the gel mix to ~4°C prior to addition of the catalysts - this prevents gel polymerisation mid-way through pouring the gel! Polymerisation of formamide gels requires longer than normal as does the actual electrophoresis.
7) Electrophorese at ~80W, constant power (should be ~45 - 50°C for a 38x50cm gel).
You will need:
A standard detergent2% dichlorodimethyl silane in hexaneAbsolute ethanol6% sequencing acrylamide (5.7% acrylamide, 0.3% bisacrylamide, 48% urea, 1x TBE)25% AMPS (freshly made)TEMED
N.B: Wear gloves while handling solutions of unpolymerised acrylamide. Unpolymerised acrylamide is a neurotoxin.
1) Clean the glass plates extensively with detergent and water, tap water, distilled water and finally ethanol. Wipe dry with a clean paper towel.
2) Siliconize the smaller of the two plates using the 4% solution of dichlorodimethylsilane in hexane. The solution should be spread evenly over the plate and allowed to dry before being repeated. Once dry, the plate should be washed with 100% ethanol and again wiped dry using a clean paper towel.
3) Gel plates are then assembled as described in the manufacturers instructions using two 0.25 -1mm wedge spacers.
Polyacrylamide sequencing mix for use in the gels was stored at 4°C in a dark bottle.
4) 35ml of the acrylamide mix is used to first plug the bottom of the gel. Chill the acrylamide on ice and add 150ul 25% AMPS and 150ul TEMED. Mix by swirling and then poured briskly into the gel mould. The quantities of AMPS and TEMED may have to be esti mated empirically to cause setting in approx. 5 minutes.
5) Once the plug has set, 85ml of acrylamide is then used to form the main gel itself. To the acrylamide (chilled on ice beforehand), add 110ul 25% AMPS and 110ul TEMED. The solutions are mixed thoroughly, placed into a 50ml syringe and injected, carefull y, between the glass plates. In order to facilitate ease of pouring, the glass plates were inclined at an angle of approximately 10° to the horizontal in a large developing tray to prevent spills. Again, the quantities of AMPS and TEMED used may need to be varied in order to give polymerisation in approx. 30 minutes - this may be especially critical if the ambient temperature is abnormally warm.
N.B: It is critical to chill the acrylamide for the main gel in order to prevent polymerisation while the gel is being poured. You may also need to adjust the AMPS/TEMED quantities used. You should aim to have the plug set in ~5 mins and the main g el after ~30 mins.
6) Immediately after the gel is poured, a flat 0.25mm spacer (or reversed shark tooth comb) should be placed into the acrylamide on the gel top such that it intrudes into the gel by approximately 10mm. This allows the formation of a flat gel surface essen tial to the effective use of the shark tooth combs during electrophoresis. Clamp large bulldog clips across the top of the gel plates during gel polymerisation to ensure a leak-free fit of the combs. Allowed to polymerise for 1 hour at room temperature an d then use directly or store overnight at 4°C, tightly wrapped in clingfilm to prevent dehydration of the gel.
7) Remove the gel former and pre-electrophorese the gel at 1800V to heat the gel and running buffer to the required operating temperature (55°C) prior to the loading of the samples. Running buffer is 1 x TBE.
8) Insert sharks tooth combs such that the tips protrude approximately 0.5mm into the gel surface.
9) Thoroughly wash the wells immediately prior to the loading of the samples with running buffer to remove any urea which leaches from the gel.
10) Sequencing reaction mixtures, containing loading buffer, should be boiled for 2-3 minutes to denature any secondary structure and loaded into the wells (3ul/well), in the order G, A, T, C.
11) Electrophorese at 1800V (preferably 75W constant power) until the xylene cyanol dye front is approximately 5 cm from the bottom of the gel. Monitor the gel temperature to ensure it stays at 60°C or below (preferably 50-55°C).
N.B: Allowing the gel temperature to exceed 60°C for extended periods of time will cause the hydrolysis of urea in the gel.
12) After electrophoresis is complete, combs should be removed and the small siliconized glass plate gently removed from the remaining plate. The large plate, with the gel still attached, is then immersed in a fixative solution containing 10% acetic acid, 10% methanol for approximately 15-20 minutes. This process is used to remove urea from the gel.
13) Transfer the gel to a large sheet of Whatman 3MM paper and dry on a vacuum gel drier at 85°C for 75 minutes prior to autoradiography.
--------------------------------------------------------------------------------
Addendum submitted at 17:32 on 08/02/96 by: Dr. Simon Dawson,Department of Biochemistry,University of Nottingham,The Medical School,Q.M.C.,Clifton Boulevard,Nottingham,NG7 2UH,U.K.Tel: +44 115 9249924 Ex. 44787,FAX: +44 115 9422225,Email: Simon.Dawson@nott.ac.uk
This addendum describes the use of formamide in sequencing gels to alleviate problems with base stacking due to G-C compressions. The following method describes the production of 200ml of a 25% formamide, 6% acrylamide sequencing gel mix but it can be scaled accordingly. You can also vary the formamide concentration upto 40%.
You will need:
Ultra-pure ureaFormamideAcrylamideBis-acrylamideTEMEDAmmonium persulphate (AMPS)Amberlite MB-1 resin (Sigma)10 x TBE buffer
1) Mix together 82g urea, 50ml formamide, 11.4g acrylamide, 0.6g bis-acrylamide and ~60ml H2O.
2) Warm the mixture to ~40°C, with stirring, to dissolve solids.
N.B.: Do not heat the mixture above 55°C as this leads to hydrolysis of the urea.
3) Once dissolved, add ~5g Amberlite MB-1 resin and stir for 20 minutes.
4) Filter solution (we typically use Whatman 3MM paper) and make up to 180ml with H2O.
5) Add 20ml fresh 10 x TBE buffer.
6) For a gel of ~100ml, use 200ul TEMED and 200ul fresh 25% AMPS solution to initiate polymerisation.
N.B.: For the above quantities of TEMED and AMPS, you MUST chill the gel mix to ~4°C prior to addition of the catalysts - this prevents gel polymerisation mid-way through pouring the gel! Polymerisation of formamide gels requires longer than normal as does the actual electrophoresis.
7) Electrophorese at ~80W, constant power (should be ~45 - 50°C for a 38x50cm gel).
DNA Sequencing
The sequencing reactions described below work perfectly well if you are short of cash to buy sequencing kits. It is based on the Dideoxy sequencing method of Sanger et al., 1977. However, due to the number solutions that need to be made, I recommend purch asing a sequencing kit, we use either the T7 Sequencing Kit (Pharmacia, 100 reactions) or the Sequenase 2.0 Sequencing Kit (USB via Amersham in the U.K., 100 reactions). Reactions are performed in sterile 1.5ml microcentrifuge tubes. Primers are synthesised on an Applied Biosystems 381A DNA synthesiser.
Approximately 3ug denatured, high quality dsDNA (i.e. prepared as described in 'Plasmid Isolation using PEG') are typically used for standard sequencing reactions.
DNA Sequencing Reactions
You will need:
Freshly made 2M NaOH3M sodium acetate, pH 4.5Sterile, distilled waterAbsolute ethanol70% ethanol7 x DNA annealing buffer (280mM Tris.Cl, pH 7.5, 100mM MgCl2, 350mM NaCl)Termination mixes (40mM Tris.Cl, pH 7.5, 50mM NaCl, 10mM MgCl2, 150mM dTTP, 150mM dATP, 150mM dCTP, 150mM c7deaza-dGTP and 15mM of the respective ddNTP)5 x DNA labelling mix (10mM dGTP, 10mM dCTP, 10mM dTTP, 200mM Tris.Cl, pH 7.5, 250mM NaCl)300mM DTT[a-35S]-dATP (~ 1000Ci/mmol, Amersham or DuPont)T7 DNA polymerase (Pharmacia)Stop solution (95% deionized formamide, 20mM EDTA, pH 7.5, 0.1% each of bromophenol blue and xylene cyanol FF)
1) Denature dsDNA by the addition of 8ul DNA (approximately 3ug) to a sterile microcentrifuge tube containing 2ul freshly made 2M NaOH vortexed briefly and incubate at room temperature for 10 minutes.
2) Neutralise DNA by the addition of 3ul 3M sodium acetate, pH 4.5 and 7ul sterile, distilled H2O and precipitate by the addition of 60ul ethanol. Recover DNA by centrifugation, at maximum speed, for 10 minutes in a microfuge. Rinse DNA briefly in 70% ethanol, air dry and re-dissolve in 10ul sterile, distilled H2O.
3) To a microcentrifuge tube containing 10ml denatured template DNA, add 4.44ng primer (2ul of a 2.22ng/ul stock) and 2ml 7 x annealing buffer. Heat the mixture to 65°C for 2 minutes and allow to cool slowly, over a period of about 30 minutes, to roo m temperature.
4) While the annealing reaction is taking place, take 4 sterile microcentrifuge tubes per sample and label G, A, T, C, respectively. Place into each tube 2.5ul, respectively, of the corresponding termination mix. Pre-warm tubes to 37°C.
5) After completion of the annealing reaction, the labelling reaction is initiated by the addition to the annealed template/primer of 2ul 1 x labelling mix, 1ul 300mM DTT, 1ul [a-35S]-dATP (~ 1000Ci/mmol) and 3 units T7 DNA polymerase (2ul of a 1.5 units/ ul solution). The solution is pipetted briefly to mix the components and incubated at 4°C for 2-5 minutes.
6) Termination is achieved by transferring 4.5ul of the labelling reaction into each of the 4 tubes labelled G, A, T, C, respectively and incubating at 37°C for 2-5 minutes.
7) After termination, 5ul stop solution should be added to each tube, mixed by pipetting and the samples stored at -20°C for later use.
Approximately 3ug denatured, high quality dsDNA (i.e. prepared as described in 'Plasmid Isolation using PEG') are typically used for standard sequencing reactions.
DNA Sequencing Reactions
You will need:
Freshly made 2M NaOH3M sodium acetate, pH 4.5Sterile, distilled waterAbsolute ethanol70% ethanol7 x DNA annealing buffer (280mM Tris.Cl, pH 7.5, 100mM MgCl2, 350mM NaCl)Termination mixes (40mM Tris.Cl, pH 7.5, 50mM NaCl, 10mM MgCl2, 150mM dTTP, 150mM dATP, 150mM dCTP, 150mM c7deaza-dGTP and 15mM of the respective ddNTP)5 x DNA labelling mix (10mM dGTP, 10mM dCTP, 10mM dTTP, 200mM Tris.Cl, pH 7.5, 250mM NaCl)300mM DTT[a-35S]-dATP (~ 1000Ci/mmol, Amersham or DuPont)T7 DNA polymerase (Pharmacia)Stop solution (95% deionized formamide, 20mM EDTA, pH 7.5, 0.1% each of bromophenol blue and xylene cyanol FF)
1) Denature dsDNA by the addition of 8ul DNA (approximately 3ug) to a sterile microcentrifuge tube containing 2ul freshly made 2M NaOH vortexed briefly and incubate at room temperature for 10 minutes.
2) Neutralise DNA by the addition of 3ul 3M sodium acetate, pH 4.5 and 7ul sterile, distilled H2O and precipitate by the addition of 60ul ethanol. Recover DNA by centrifugation, at maximum speed, for 10 minutes in a microfuge. Rinse DNA briefly in 70% ethanol, air dry and re-dissolve in 10ul sterile, distilled H2O.
3) To a microcentrifuge tube containing 10ml denatured template DNA, add 4.44ng primer (2ul of a 2.22ng/ul stock) and 2ml 7 x annealing buffer. Heat the mixture to 65°C for 2 minutes and allow to cool slowly, over a period of about 30 minutes, to roo m temperature.
4) While the annealing reaction is taking place, take 4 sterile microcentrifuge tubes per sample and label G, A, T, C, respectively. Place into each tube 2.5ul, respectively, of the corresponding termination mix. Pre-warm tubes to 37°C.
5) After completion of the annealing reaction, the labelling reaction is initiated by the addition to the annealed template/primer of 2ul 1 x labelling mix, 1ul 300mM DTT, 1ul [a-35S]-dATP (~ 1000Ci/mmol) and 3 units T7 DNA polymerase (2ul of a 1.5 units/ ul solution). The solution is pipetted briefly to mix the components and incubated at 4°C for 2-5 minutes.
6) Termination is achieved by transferring 4.5ul of the labelling reaction into each of the 4 tubes labelled G, A, T, C, respectively and incubating at 37°C for 2-5 minutes.
7) After termination, 5ul stop solution should be added to each tube, mixed by pipetting and the samples stored at -20°C for later use.
DNA Fragmentation Assay via Dipheylamine
Protocol I: Triton X-100 Lysis Buffer
In 96 flat-wells plate, incubate 4x10 6 target cells (40 wells of 105 per well) with desired concentration of effectors (105 target cells per well). After incubation, collect the cell sample in 1.5 ml eppendorf tube, spin down, resuspend with 0.5 ml PBS in 1.5 ml eppendorf tubes, and add 55ul of lysis buffer for 20 min on ice (4oC). Centrifuge the eppendorf tubes in cold at 12,000 g for 30 minutes. Transfer the samples to new 1.5 ml eppendorf tubes and then extract the supernatant with 1:1 mixture of phenol:chloroform (gentle agitation for 5 min followed by centrifugation) and precipitate in two equivalence of cold ethanol and one-tenth equivalence of sodium acetate. Spin down, decant, and resuspend the precipitates in 30ul of deionized water-RNase solution (0.4ml water + 5ul of RNase) and 5ul of loading buffer for 30 minutes at 37oC. Also insert 2ul of Hindi III marker (12ul of Stock IV) on the outer lanes. Run the 1.2% gel at 5V for 5min before increasing to 100V.
Protocol II: SDS LysisBuffer
Add SDS lysis buffer to the incubated cell samples (prepared as in Protocol I).
Stock I:Triton X-100 Lysis Buffer 40 ml of 0.5 M EDTA 5 ml of 1 M TrisCl buffer pH 8.0 5 ml of 100% Triton X-100 50 ml of H2OStock II: SDS Lysis Buffer
Stock III: 1.2% Agarose Gel
Prepare a stock of 2 liter of 1X TAE (i.e., 2 liter + 40ml of 5X TAE). Add 2.4g of agarose power(1.2% agarose) to 200ml of 1X TAE solution and microwave for 4 min at high power. Then cool the gel to 50oC and add 25ul of ethium bromide before pouring it into the gel plate. Insert comb and let the gel polymerized.
Stock IV: Hindi III Marker (50 Kb lamda DNA) 4ul of Hindi III Marker 16ul of Deionized Water 4ul of Loading Buffer
Protocol III: DNA Fragmentation Assay via Dipheylamine
In 24-wells plate, incubate 5 X 106 targets with desired number of effectors. After incubation, transfer the samples to 15ml tubes, centrifuge for 30 s at 1500g, and resuspend in 5ml of lysis buffer (Stock IV) for 15 min on ice. Centrifuge the samples for 20 min at 27,000g to separate high-molecular-weight chromatin from cleavage products. Resuspend the pellet in 5 ml of buffer (stock V).
reat the supernatants and pellets with the diphenylamine reagent (Stock VI) and incubate at 370C for 16-24 hr before colorimetric assessment.
Stock IV: Lysis buffer at pH 8.0 5mM Tris-HCl 20mM EDTA 0.5% Triton X-100
Stock V: Buffer at pH 8.0 10mM Tris-HCl 1mM EDTA
Stock VI: Diphenylamine reagent (light sensitive) 1.5g of diphenylamine (steam-distilled) 100ml acetic acid (redistilled) 1.5ml of conc. sulfuric acid
On the day of usage, add 0.10ml of ag acetaldehyde (16mg/ml) to 20ml of the diphenylamine reagent.
Protocol IV: DNA Fragmentation via 3H-TdR
5 X 106 target cells were labeled with 50µl of 3H-TdR (1 mCi/ml) overnight in 10 ml of media. The next day, the cells were washed 3X with 10ml of PBS and incubated in 10ml of media to chase out unincorporated cytoplasmic 3H-TdR. After incubating for 2 hrs, the cells were washed 3X with PBS and then used in lytic assay under the same conditions as the 51Cr release assay in 96 v-well plates. At the end of the assay, each well was treated with 20µl of 1.0% Triton-X on ice for 5 minutes, followed by centrifugation at 1500g in a Beckman T-J6 rotor for 15 minutes. 100µl of the supernatant were harvested from each well and counted in a scintillation counter. Total count was obtained by resuspending the cells prior to harvesting, and adding 0.1% SDS to solublilize the cells. The % 3H released was calculated with an equation analogous to that for %51Cr released.
In 96 flat-wells plate, incubate 4x10 6 target cells (40 wells of 105 per well) with desired concentration of effectors (105 target cells per well). After incubation, collect the cell sample in 1.5 ml eppendorf tube, spin down, resuspend with 0.5 ml PBS in 1.5 ml eppendorf tubes, and add 55ul of lysis buffer for 20 min on ice (4oC). Centrifuge the eppendorf tubes in cold at 12,000 g for 30 minutes. Transfer the samples to new 1.5 ml eppendorf tubes and then extract the supernatant with 1:1 mixture of phenol:chloroform (gentle agitation for 5 min followed by centrifugation) and precipitate in two equivalence of cold ethanol and one-tenth equivalence of sodium acetate. Spin down, decant, and resuspend the precipitates in 30ul of deionized water-RNase solution (0.4ml water + 5ul of RNase) and 5ul of loading buffer for 30 minutes at 37oC. Also insert 2ul of Hindi III marker (12ul of Stock IV) on the outer lanes. Run the 1.2% gel at 5V for 5min before increasing to 100V.
Protocol II: SDS LysisBuffer
Add SDS lysis buffer to the incubated cell samples (prepared as in Protocol I).
Stock I:Triton X-100 Lysis Buffer 40 ml of 0.5 M EDTA 5 ml of 1 M TrisCl buffer pH 8.0 5 ml of 100% Triton X-100 50 ml of H2OStock II: SDS Lysis Buffer
Stock III: 1.2% Agarose Gel
Prepare a stock of 2 liter of 1X TAE (i.e., 2 liter + 40ml of 5X TAE). Add 2.4g of agarose power(1.2% agarose) to 200ml of 1X TAE solution and microwave for 4 min at high power. Then cool the gel to 50oC and add 25ul of ethium bromide before pouring it into the gel plate. Insert comb and let the gel polymerized.
Stock IV: Hindi III Marker (50 Kb lamda DNA) 4ul of Hindi III Marker 16ul of Deionized Water 4ul of Loading Buffer
Protocol III: DNA Fragmentation Assay via Dipheylamine
In 24-wells plate, incubate 5 X 106 targets with desired number of effectors. After incubation, transfer the samples to 15ml tubes, centrifuge for 30 s at 1500g, and resuspend in 5ml of lysis buffer (Stock IV) for 15 min on ice. Centrifuge the samples for 20 min at 27,000g to separate high-molecular-weight chromatin from cleavage products. Resuspend the pellet in 5 ml of buffer (stock V).
reat the supernatants and pellets with the diphenylamine reagent (Stock VI) and incubate at 370C for 16-24 hr before colorimetric assessment.
Stock IV: Lysis buffer at pH 8.0 5mM Tris-HCl 20mM EDTA 0.5% Triton X-100
Stock V: Buffer at pH 8.0 10mM Tris-HCl 1mM EDTA
Stock VI: Diphenylamine reagent (light sensitive) 1.5g of diphenylamine (steam-distilled) 100ml acetic acid (redistilled) 1.5ml of conc. sulfuric acid
On the day of usage, add 0.10ml of ag acetaldehyde (16mg/ml) to 20ml of the diphenylamine reagent.
Protocol IV: DNA Fragmentation via 3H-TdR
5 X 106 target cells were labeled with 50µl of 3H-TdR (1 mCi/ml) overnight in 10 ml of media. The next day, the cells were washed 3X with 10ml of PBS and incubated in 10ml of media to chase out unincorporated cytoplasmic 3H-TdR. After incubating for 2 hrs, the cells were washed 3X with PBS and then used in lytic assay under the same conditions as the 51Cr release assay in 96 v-well plates. At the end of the assay, each well was treated with 20µl of 1.0% Triton-X on ice for 5 minutes, followed by centrifugation at 1500g in a Beckman T-J6 rotor for 15 minutes. 100µl of the supernatant were harvested from each well and counted in a scintillation counter. Total count was obtained by resuspending the cells prior to harvesting, and adding 0.1% SDS to solublilize the cells. The % 3H released was calculated with an equation analogous to that for %51Cr released.
DNA Fingerprinting
Perhaps one of the most disquieting elements in our justice system today is the thought of wrongfully convicting or even sentencing to death the innocent. Biochemistry, in the development of DNA forensics, provides justice a more decisive scale in weighing the innocence or guilt of an individual.
In 1985 Ronald Cotton was imprisoned for the rape of Jennifer Thompson. She had identified him from pictures and a line-up as the assailant. Circumstantial evidence stacked up against Cotton making it quite clear that Cotton was guilty. He was imprisoned with no flaw in the judicial system to speak of, except one…he was innocent. After 10 years of imprisonment, biochemical technology allowed the comparison of Cotton’s DNA to that of the rapist’s semen, proving his innocence beyond a shadow of a doubt. The same evidence was then used to rightfully convict Robert Poole, a convict who had mentioned the rape to fellow inmates.Since the early 1980’s DNA "fingerprints" have been used to convict or release possible suspects involved in many crimes. The use of these fingerprints by the FBI’s Forensic Science Systems Unit to form the national DNA registry called, Combined DNA Index System (CODIS), is perhaps one of the greatest assets to criminal investigators to date. It is the goal of the FBI to have the Index operating much like the Automated Fingerprint Index System (AFIS). The Standardization Project has insured that all of the genetic information collected across the United States is in a comparable format. All states have authorized the submission of DNA from violent criminals and sexual offenders to CODIS. Almost any type of biological evidence found at a crime scene may be compared to a suspect, including: blood, semen, saliva, bone, tissue, teeth, and even hair follicles.
he methods for obtaining and comparing the genetic samples of evidence and suspects were originally developed to determine the compatibility of Human Leukocyte Antigens (HLA) in individuals for organ and bone marrow transplants. These antigens are highly specific to an individual and are used by the body’s immune system to determine self from non-self. If a transplant is made without first comparing the compatibility of these antigens, there is a very high likelihood that the donated tissue will be rejected and attacked by the recipient’s immune system. The high amount of specificity allows the regions of DNA encoding for the antigens to be extremely useful in identifying one out of several million people. The commonly used methods for isolating and comparing genetic sequences include polymerase chain reactions (PCR) and restriction fragment length polymorphisms (RFLP).
The process for PCR is commonly used to analyze genetic information in many genetic investigations. Even a few molecules of DNA can be amplified to produce large quantities. This property makes PCR ideal for analyzing small samples of DNA. The laboratory procedure involves a cycle of denaturing, annealing, and extending DNA. An increase of temperature triggers denaturing. The hydrogen bonds break between the double stranded helix and they separate. In the process of annealing, the temperature is lowered, which enables primers to attach. Primers are segments of DNA having a free OH group on the 3’ carbon of a nucleotide. These primers align with a very specific sequence of amino acids. After the temperature is increased slightly, a DNA polymerase is able to attach nucleotides to the 3’ carbon of the primer and extend the complementary strand. Each temperature-regulated cycle greatly increases the amount of DNA present, which makes more available for amplification in the next cycle.
For analysis, the PCR product is heated once again and washed over a typing strip. These typing strips are composed of different variations of the alleles amplified during the PCR process. HLA DQa was the first type of strip to be used for forensic analysis. The strip is made by fixing Sequence-Specific Oligonucleotide (SSO) probes to a support. The HLA DQa strip tests for the presence of six different kinds of DQa alleles. There are four main types of alleles fixed to the strip. The 1 allele is then subtyped into 1.1,1.2 and 1.3. The SSOs are placed in nine dots along the strip. The first four probes test for alleles 1-4 respectively. The fifth dot is a control that will attach to any DQa type. Any dot lighter than the control probe is considered invalid. The sixth probe is for the subtype 1.1. The seventh probe will indicate a positive response for 1.2, 1.3 or 4. The eighth detects the presence of subtype 1.3. The last probe will respond to every allele except the 1.3 subtype. These SSO probes grab on to complementary PCR-amplified fragments as they are washed over the strip. The strips are then washed to remove any unattached fragments of DNA. The detection of the DNA on the probe goes back to the primers used during PCR. All of these primers were tagged with biotin. The presence of biotin allows streptavidin to bond to the fragments after they attach to the strip. The streptavidin is chemically linked to horseradish peroxidase (HRP). HRP emits the color blue when in the presence of hydrogen peroxide and tetra-methyl-benzidine (TMB). The resulting strip can then be viewed for analysis. Modern forensics uses an HLA DQA1 testing strip. The advantage of the new strip is the detection of the allele 4 subtypes as well as the allele 1 subtypes.
RFLP comparisons are much more specific tests, but require DNA samples of very high quality to work effectively. The procedures are also much more labor-intensive than PCR. First a restriction endonuclease is used to cut the DNA into millions of fragments. The restriction endonuclease is able to cut a strand when it comes across a specific sequence of nucleotides. These fragments are separated by gel electrophoresis based on their relative sizes. Smaller fragments have less drag in the gel and are carried further by the current. NaOH is then added to the gel to alter the pH and break the duplex DNA molecules into singular strands. The fragments are transferred to a nylon membrane in a process called Southern Blotting. In this procedure the nylon membrane is placed on top of the gel. Absorptive material is then placed on top of the membrane, pulling the gel through the nylon into the material. The DNA is carried in the gel medium to the nylon membrane where it is fixed to the sheet. The membrane is baked to more tightly attach the DNA fragments. To ensure no other DNA molecules can attach to the sheet, protein or detergent is added, which blocks all of the vacant spots where a DNA fragment could attach. Now the only way a DNA molecule can bond to the sheet is if it is complementary to the single stranded DNA already fixed to it. Probe fragments of specific genes are then made radioactive and washed over the membrane. If the complementary segment is present on the membrane, the probe will attach. After washing away the unattached probes, X-ray film or a phosphorimager can then be used to detect the presence of an attached probe and thus the presence of the gene in the sample. The variability in the types and sizes of probes allow RFLP to reveal a large amount of very specific information. The membrane can be cleaned of any probe and retested with another providing an even larger amount of data.
As the O.J. Simpson trial best exemplified, one must not be too quick to judge DNA fingerprinting as a fail proof method of determining truth. In this trial both PCR and RFLP methods of analysis were applied to 45 bloodstains. At the scene of the murder, 8 drops of blood along the walkway and back gate were found to be O.J. Simpson’s. Seven bloodstains in O.J.’s Bronco were found to be Nichole Brown and/or Ronald Goldman’s. Three drops of Nichole Brown’s blood were found on O.J. Simpson’s socks and 11 bloodstains found on the Rockingham glove contained the victims’ DNA. In spite of all of this biochemical data indicating O.J. Simpson as the murderer, the defense was able to convince the jury that genetic evidence is only as reliable as those who are in charge of the tests and a verdict of not guilty was pronounced.
Nevertheless, today’s courts are filling up with appeals on the grounds of new reliable genetic evidence. Many innocent men and women can now be justly returned to their freedom. The number of overturned rulings has even fueled the movement against the death penalty as people repeatedly witness just how many false convictions there are. Cases like those of Ronald Cotton are showing that even an eyewitness many not be as reliable as the witness provided in the genetic fabric of life itself.
The maximum potential for this technology is far from being attained. The days may be approaching when a hair follicle dropped into a computer produces the picture of the guilty party in seconds. Why bother even sending police out to look for them? If that hair follicle has the criminal’s antigen information on it, isn’t it possible to produce a virus that targets that individual's unique HLA profile? Then release the virus and wait at the hospital or morgue for the right symptoms. It sounds drastic, but it may be possible…
In 1985 Ronald Cotton was imprisoned for the rape of Jennifer Thompson. She had identified him from pictures and a line-up as the assailant. Circumstantial evidence stacked up against Cotton making it quite clear that Cotton was guilty. He was imprisoned with no flaw in the judicial system to speak of, except one…he was innocent. After 10 years of imprisonment, biochemical technology allowed the comparison of Cotton’s DNA to that of the rapist’s semen, proving his innocence beyond a shadow of a doubt. The same evidence was then used to rightfully convict Robert Poole, a convict who had mentioned the rape to fellow inmates.Since the early 1980’s DNA "fingerprints" have been used to convict or release possible suspects involved in many crimes. The use of these fingerprints by the FBI’s Forensic Science Systems Unit to form the national DNA registry called, Combined DNA Index System (CODIS), is perhaps one of the greatest assets to criminal investigators to date. It is the goal of the FBI to have the Index operating much like the Automated Fingerprint Index System (AFIS). The Standardization Project has insured that all of the genetic information collected across the United States is in a comparable format. All states have authorized the submission of DNA from violent criminals and sexual offenders to CODIS. Almost any type of biological evidence found at a crime scene may be compared to a suspect, including: blood, semen, saliva, bone, tissue, teeth, and even hair follicles.
he methods for obtaining and comparing the genetic samples of evidence and suspects were originally developed to determine the compatibility of Human Leukocyte Antigens (HLA) in individuals for organ and bone marrow transplants. These antigens are highly specific to an individual and are used by the body’s immune system to determine self from non-self. If a transplant is made without first comparing the compatibility of these antigens, there is a very high likelihood that the donated tissue will be rejected and attacked by the recipient’s immune system. The high amount of specificity allows the regions of DNA encoding for the antigens to be extremely useful in identifying one out of several million people. The commonly used methods for isolating and comparing genetic sequences include polymerase chain reactions (PCR) and restriction fragment length polymorphisms (RFLP).
The process for PCR is commonly used to analyze genetic information in many genetic investigations. Even a few molecules of DNA can be amplified to produce large quantities. This property makes PCR ideal for analyzing small samples of DNA. The laboratory procedure involves a cycle of denaturing, annealing, and extending DNA. An increase of temperature triggers denaturing. The hydrogen bonds break between the double stranded helix and they separate. In the process of annealing, the temperature is lowered, which enables primers to attach. Primers are segments of DNA having a free OH group on the 3’ carbon of a nucleotide. These primers align with a very specific sequence of amino acids. After the temperature is increased slightly, a DNA polymerase is able to attach nucleotides to the 3’ carbon of the primer and extend the complementary strand. Each temperature-regulated cycle greatly increases the amount of DNA present, which makes more available for amplification in the next cycle.
For analysis, the PCR product is heated once again and washed over a typing strip. These typing strips are composed of different variations of the alleles amplified during the PCR process. HLA DQa was the first type of strip to be used for forensic analysis. The strip is made by fixing Sequence-Specific Oligonucleotide (SSO) probes to a support. The HLA DQa strip tests for the presence of six different kinds of DQa alleles. There are four main types of alleles fixed to the strip. The 1 allele is then subtyped into 1.1,1.2 and 1.3. The SSOs are placed in nine dots along the strip. The first four probes test for alleles 1-4 respectively. The fifth dot is a control that will attach to any DQa type. Any dot lighter than the control probe is considered invalid. The sixth probe is for the subtype 1.1. The seventh probe will indicate a positive response for 1.2, 1.3 or 4. The eighth detects the presence of subtype 1.3. The last probe will respond to every allele except the 1.3 subtype. These SSO probes grab on to complementary PCR-amplified fragments as they are washed over the strip. The strips are then washed to remove any unattached fragments of DNA. The detection of the DNA on the probe goes back to the primers used during PCR. All of these primers were tagged with biotin. The presence of biotin allows streptavidin to bond to the fragments after they attach to the strip. The streptavidin is chemically linked to horseradish peroxidase (HRP). HRP emits the color blue when in the presence of hydrogen peroxide and tetra-methyl-benzidine (TMB). The resulting strip can then be viewed for analysis. Modern forensics uses an HLA DQA1 testing strip. The advantage of the new strip is the detection of the allele 4 subtypes as well as the allele 1 subtypes.
RFLP comparisons are much more specific tests, but require DNA samples of very high quality to work effectively. The procedures are also much more labor-intensive than PCR. First a restriction endonuclease is used to cut the DNA into millions of fragments. The restriction endonuclease is able to cut a strand when it comes across a specific sequence of nucleotides. These fragments are separated by gel electrophoresis based on their relative sizes. Smaller fragments have less drag in the gel and are carried further by the current. NaOH is then added to the gel to alter the pH and break the duplex DNA molecules into singular strands. The fragments are transferred to a nylon membrane in a process called Southern Blotting. In this procedure the nylon membrane is placed on top of the gel. Absorptive material is then placed on top of the membrane, pulling the gel through the nylon into the material. The DNA is carried in the gel medium to the nylon membrane where it is fixed to the sheet. The membrane is baked to more tightly attach the DNA fragments. To ensure no other DNA molecules can attach to the sheet, protein or detergent is added, which blocks all of the vacant spots where a DNA fragment could attach. Now the only way a DNA molecule can bond to the sheet is if it is complementary to the single stranded DNA already fixed to it. Probe fragments of specific genes are then made radioactive and washed over the membrane. If the complementary segment is present on the membrane, the probe will attach. After washing away the unattached probes, X-ray film or a phosphorimager can then be used to detect the presence of an attached probe and thus the presence of the gene in the sample. The variability in the types and sizes of probes allow RFLP to reveal a large amount of very specific information. The membrane can be cleaned of any probe and retested with another providing an even larger amount of data.
As the O.J. Simpson trial best exemplified, one must not be too quick to judge DNA fingerprinting as a fail proof method of determining truth. In this trial both PCR and RFLP methods of analysis were applied to 45 bloodstains. At the scene of the murder, 8 drops of blood along the walkway and back gate were found to be O.J. Simpson’s. Seven bloodstains in O.J.’s Bronco were found to be Nichole Brown and/or Ronald Goldman’s. Three drops of Nichole Brown’s blood were found on O.J. Simpson’s socks and 11 bloodstains found on the Rockingham glove contained the victims’ DNA. In spite of all of this biochemical data indicating O.J. Simpson as the murderer, the defense was able to convince the jury that genetic evidence is only as reliable as those who are in charge of the tests and a verdict of not guilty was pronounced.
Nevertheless, today’s courts are filling up with appeals on the grounds of new reliable genetic evidence. Many innocent men and women can now be justly returned to their freedom. The number of overturned rulings has even fueled the movement against the death penalty as people repeatedly witness just how many false convictions there are. Cases like those of Ronald Cotton are showing that even an eyewitness many not be as reliable as the witness provided in the genetic fabric of life itself.
The maximum potential for this technology is far from being attained. The days may be approaching when a hair follicle dropped into a computer produces the picture of the guilty party in seconds. Why bother even sending police out to look for them? If that hair follicle has the criminal’s antigen information on it, isn’t it possible to produce a virus that targets that individual's unique HLA profile? Then release the virus and wait at the hospital or morgue for the right symptoms. It sounds drastic, but it may be possible…
Sae2, Exo1 and Sgs1 collaborate in DNA double-strand break processing
DNA ends exposed after introduction of double-strand breaks (DSBs) undergo 5'–3' nucleolytic degradation to generate single-stranded DNA, the substrate for binding by the Rad51 protein to initiate homologous recombination. This process is poorly understood in eukaryotes, but several factors have been implicated, including the Mre11 complex (Mre11–Rad50–Xrs2/NBS1), Sae2/CtIP/Ctp1 and Exo1. Here we demonstrate that yeast Exo1 nuclease and Sgs1 helicase function in alternative pathways for DSB processing. Novel, partially resected intermediates accumulate in a double mutant lacking Exo1 and Sgs1, which are poor substrates for homologous recombination. The early processing step that generates partly resected intermediates is dependent on Sae2. When Sae2 is absent, in addition to Exo1 and Sgs1, unprocessed DSBs accumulate and homology-dependent repair fails. These results suggest a two-step mechanism for DSB processing during homologous recombination. First, the Mre11 complex and Sae2 remove a small oligonucleotide(s) from the DNA ends to form an early intermediate. Second, Exo1 and/or Sgs1 rapidly process this intermediate to generate extensive tracts of single-stranded DNA that serve as substrate for Rad51.
Plasma DNA Is More Reliable than Carcinoembryonic Antigen for Diagnosis of Recurrent Esophageal Cancer
Background
Carcinoembryonic antigen (CEA) and plasma DNA are known to be elevated in patients with esophageal cancer and are higher in patients with disseminated disease. The sensitivity and specificity of these markers in the diagnosis of recurrent esophageal cancer have not been compared.
Study Design
Plasma DNA was measured using polymerase chain reaction in 45 patients with esophageal cancer and 44 asymptomatic volunteers. The 95th percentile (19 ng /mL) in the volunteers was used to define normal. Thirty-nine patients had localized cancer and underwent resection, and six had disseminated disease at operation. Plasma DNA was measured preoperatively in all patients, with serum CEA measured in 31. Plasma DNA was measured sequentially during followup in 21 patients, including 7 who developed recurrence. CEA was measured in 14 of 21 patients who had sequential plasma DNA measured and in 6 of 7 patients with recurrence. CEA levels greater than 5.0 ng/mL were used as cut-off.
Results
Plasma DNA was more sensitive than CEA for detecting unresectable esophageal cancer (100% versus 40%), but it had a lower specificity (22% versus 89%).The positive predictive value (19% versus 40%) and negative predictive value (100% versus 89%) were similar for plasma DNA and serum CEA, respectively.
Plasma DNA was also more sensitive than CEA in detecting recurrent esophageal cancer (100% versus 33%). The specificity and positive predictive values were 100% for both tests, but the negative predictive values were higher for plasma DNA. Plasma DNA rose before there was clinical evidence of recurrence in 67% compared with only 17% for CEA.
Conclusions
Elevated plasma DNA is an extremely reliable indicator of the presence of recurrent disease, and, in the majority of patients, it rises before clinical evidence of recurrence. In contrast, a normal CEA should be interpreted cautiously, because it does not exclude recurrent disease.
Carcinoembryonic antigen (CEA) and plasma DNA are known to be elevated in patients with esophageal cancer and are higher in patients with disseminated disease. The sensitivity and specificity of these markers in the diagnosis of recurrent esophageal cancer have not been compared.
Study Design
Plasma DNA was measured using polymerase chain reaction in 45 patients with esophageal cancer and 44 asymptomatic volunteers. The 95th percentile (19 ng /mL) in the volunteers was used to define normal. Thirty-nine patients had localized cancer and underwent resection, and six had disseminated disease at operation. Plasma DNA was measured preoperatively in all patients, with serum CEA measured in 31. Plasma DNA was measured sequentially during followup in 21 patients, including 7 who developed recurrence. CEA was measured in 14 of 21 patients who had sequential plasma DNA measured and in 6 of 7 patients with recurrence. CEA levels greater than 5.0 ng/mL were used as cut-off.
Results
Plasma DNA was more sensitive than CEA for detecting unresectable esophageal cancer (100% versus 40%), but it had a lower specificity (22% versus 89%).The positive predictive value (19% versus 40%) and negative predictive value (100% versus 89%) were similar for plasma DNA and serum CEA, respectively.
Plasma DNA was also more sensitive than CEA in detecting recurrent esophageal cancer (100% versus 33%). The specificity and positive predictive values were 100% for both tests, but the negative predictive values were higher for plasma DNA. Plasma DNA rose before there was clinical evidence of recurrence in 67% compared with only 17% for CEA.
Conclusions
Elevated plasma DNA is an extremely reliable indicator of the presence of recurrent disease, and, in the majority of patients, it rises before clinical evidence of recurrence. In contrast, a normal CEA should be interpreted cautiously, because it does not exclude recurrent disease.
PlateSelect™ RNAi
PlateSelect™ RNAi are customizable 96-well RNAi duplexes. This format is ideal for researchers who want small amounts of RNAi duplexes in a ready-to-transfect plate format.
#rightRTE blockquote { margin-left: 10px; margin-right: 10px }
#mainRTE blockquote { margin-left: 20px; margin-right: 20px }
RNAi duplexes in customizable 96-well plates
Select well orientation in 96-well plates and choose from Invitrogen’s Stealth™ or BLOCK-iT™ RNAi duplexes. The RNAi duplexes are provided at 1 nmol/well, and they are synthesized on demand, based on the most-up-to-date bioinformatics to reduce the chances of off-target effects.
Select the sequence and orientation of your duplexes to match your transfection protocol
Minimize off-target effects with on-demand, synthesized duplexes based on the most up-to-date bioinformatics
Order 1 to 96 duplexes per plate in a convenient 1 nmol scale—no minimum order
Choose Stealth™ RNAi chemically modified duplexes or BLOCK-iT™ RNAi duplexes using an easy-to-use interface
#rightRTE blockquote { margin-left: 10px; margin-right: 10px }
#mainRTE blockquote { margin-left: 20px; margin-right: 20px }
RNAi duplexes in customizable 96-well plates
Select well orientation in 96-well plates and choose from Invitrogen’s Stealth™ or BLOCK-iT™ RNAi duplexes. The RNAi duplexes are provided at 1 nmol/well, and they are synthesized on demand, based on the most-up-to-date bioinformatics to reduce the chances of off-target effects.
Select the sequence and orientation of your duplexes to match your transfection protocol
Minimize off-target effects with on-demand, synthesized duplexes based on the most up-to-date bioinformatics
Order 1 to 96 duplexes per plate in a convenient 1 nmol scale—no minimum order
Choose Stealth™ RNAi chemically modified duplexes or BLOCK-iT™ RNAi duplexes using an easy-to-use interface
BLOCK-iT™ Pol II miR RNAi Vector Services
BLOCK-iT? Pol II miR RNAi Vector ServicesDNA based or vector mediated RNA Interference (RNAi) is often used for long-term expression, hard to transfect cell lines or for inducible RNAi. Vector technologies allow you to:
Achieve transient or stable target knockdownPerform RNAi in any cell type – even hard to transfect, primary and non-diving cellsRegulate gene inhibition with inducible RNAi expressionStudy long-term gene knockdown
BLOCK-iT? Pol II miR RNAi vectors combine the benefits of traditional RNAi vectors – stable expression and the ability to use viral delivery – with capabilities for tissue-specific expression and multiple target knockdown from the same transcript. These vectors are designed to express artificial miRNAs that are engineered to have 100% homology to your target gene and result in target cleavage.
Table 1: BLOCK-iT? Pol II miR RNAi Entry VectorsmiR RNAi Entry Vector Advantages pcDNA?6.2- GW/miR Pol II CMV Promoter for constitutive, transient expressionPoly-cistronic miR RNAi expressionTransfer miR RNAi cassettes into other Gateway? pDEST? vectors including Lentiviral vectors pcDNA?6.2- GW/EmGFP- miR Co-cistronic EmGFP reporter for easy tracking of miR RNAi expressionPol II CMV Promoter for constitutive, transient expressionPoly-cistronic miR RNAi expressionTransfer miR RNAi cassettes into other Gateway? pDEST? vectors including Lentiviral vectors
Once your miR RNAi entry vector is generated, our RNAi services team will transfect it into mammalian cells to perform knockdown studies, chain multiple miR RNAi sequences together to knock down more than one target with the same vector, or transfer the miR RNAi sequence to another destination vector. Regardless of your vector choice, once expressed in a cell, the miR RNAi sequence induces an RNAi response resulting in knockdown of the targeted message.
Subcloning BLOCK-iT? Pol II miR RNAi SequencesThe BLOCK-iT? Pol II miR RNAi Subcloning Service includes a Gateway? BP and subsequent LR recombination reaction to move the miR RNAi sequence from the miR RNAi entry vector into the Gateway? destination vector of your choice. Currently there are many compatible destination vectors to choose from including lentiviral vectors and vectors with tissue specific promoters. Each destination vector has different features and benefits for increased flexibility in your experiments. We’ll help you choose the best destination vector that meets your experimental goals.
BLOCK-iT? Lentivirus ProductionFor many disease models the most desirable cell types to use, such as non-dividing or primary cells, cannot be efficiently transfected. Invitrogen’s lentiviral delivery system solves this problem by offering a powerful alternative to routine transfections. Lentiviral delivery has proven to be successful with a variety of cell types including:
Post mitotic or non-dividing cellsPrimary cellsStem cellsGrowth arrested cellsAnimal models
Once your BLOCK-iT? Pol II miR RNAi sequence is in a lentiviral destination vector, Invitrogen’s virus production team can produce either crude or concentrated lentiviral stocks in a variety of quantities and formats to meet your experimental goals.
BLOCK-iT? Pol II miR RNAi Phenotypic AssaysThe ultimate goal of gene knockdown is to observe changes in phenotype. Invitrogen’s Custom Services will work with you to design and execute a wide variety of phenotypic assays using BLOCK-iT? Pol II miR RNAi vectors.
BLOCK-iT? Pol II miR RNAi Custom ResearchInvitrogen’s team of expert scientists has years of experience working with RNAi and will work with you to design your RNAi experiments to reliably achieve your research goals. For more information on any of the BLOCK-iT? Pol II miR RNAi Custom Services listed here, please contact Invitrogen Custom Services.
Achieve transient or stable target knockdownPerform RNAi in any cell type – even hard to transfect, primary and non-diving cellsRegulate gene inhibition with inducible RNAi expressionStudy long-term gene knockdown
BLOCK-iT? Pol II miR RNAi vectors combine the benefits of traditional RNAi vectors – stable expression and the ability to use viral delivery – with capabilities for tissue-specific expression and multiple target knockdown from the same transcript. These vectors are designed to express artificial miRNAs that are engineered to have 100% homology to your target gene and result in target cleavage.
Table 1: BLOCK-iT? Pol II miR RNAi Entry VectorsmiR RNAi Entry Vector Advantages pcDNA?6.2- GW/miR Pol II CMV Promoter for constitutive, transient expressionPoly-cistronic miR RNAi expressionTransfer miR RNAi cassettes into other Gateway? pDEST? vectors including Lentiviral vectors pcDNA?6.2- GW/EmGFP- miR Co-cistronic EmGFP reporter for easy tracking of miR RNAi expressionPol II CMV Promoter for constitutive, transient expressionPoly-cistronic miR RNAi expressionTransfer miR RNAi cassettes into other Gateway? pDEST? vectors including Lentiviral vectors
Once your miR RNAi entry vector is generated, our RNAi services team will transfect it into mammalian cells to perform knockdown studies, chain multiple miR RNAi sequences together to knock down more than one target with the same vector, or transfer the miR RNAi sequence to another destination vector. Regardless of your vector choice, once expressed in a cell, the miR RNAi sequence induces an RNAi response resulting in knockdown of the targeted message.
Subcloning BLOCK-iT? Pol II miR RNAi SequencesThe BLOCK-iT? Pol II miR RNAi Subcloning Service includes a Gateway? BP and subsequent LR recombination reaction to move the miR RNAi sequence from the miR RNAi entry vector into the Gateway? destination vector of your choice. Currently there are many compatible destination vectors to choose from including lentiviral vectors and vectors with tissue specific promoters. Each destination vector has different features and benefits for increased flexibility in your experiments. We’ll help you choose the best destination vector that meets your experimental goals.
BLOCK-iT? Lentivirus ProductionFor many disease models the most desirable cell types to use, such as non-dividing or primary cells, cannot be efficiently transfected. Invitrogen’s lentiviral delivery system solves this problem by offering a powerful alternative to routine transfections. Lentiviral delivery has proven to be successful with a variety of cell types including:
Post mitotic or non-dividing cellsPrimary cellsStem cellsGrowth arrested cellsAnimal models
Once your BLOCK-iT? Pol II miR RNAi sequence is in a lentiviral destination vector, Invitrogen’s virus production team can produce either crude or concentrated lentiviral stocks in a variety of quantities and formats to meet your experimental goals.
BLOCK-iT? Pol II miR RNAi Phenotypic AssaysThe ultimate goal of gene knockdown is to observe changes in phenotype. Invitrogen’s Custom Services will work with you to design and execute a wide variety of phenotypic assays using BLOCK-iT? Pol II miR RNAi vectors.
BLOCK-iT? Pol II miR RNAi Custom ResearchInvitrogen’s team of expert scientists has years of experience working with RNAi and will work with you to design your RNAi experiments to reliably achieve your research goals. For more information on any of the BLOCK-iT? Pol II miR RNAi Custom Services listed here, please contact Invitrogen Custom Services.
Structure of WDR5 bound to mixed lineage Leukemia protein-1 peptide
The Mixed Lineage Leukemia protein-1 (MLL1) catalyzes histone H3 Lysine 4 methylation and is regulated by interaction with WDR5 (WD-repeat protein-5), RbBP5 (Retinoblastoma Binding Protein-5), and the Ash2L (Absent, small, homeotic discs-2-like) oncoprotein. In the accompanying investigation, we describe the identification of a conserved arginine containing motif, called the “Win” or WDR5 interaction motif that is essential for the assembly and H3K4 dimethylation activity of the MLL1 core complex. Here we present a 1.7-? crystal structure of WDR5 bound to a peptide derived from the MLL1 Win motif. Our results show that R3765 of the MLL1 is bound in the same arginine binding pocket on WDR5 that was previously suggested to bind histone H3. Thermodynamic binding experiments show that the MLL1 Win peptide is preferentially recognized by WDR5. These results are consistent with a model in which WDR5 recognizes R3765 of MLL1, which is essential for the assembly and enzymatic activity of the MLL1 core complex.
A conserved arginine containing motif crucial for the assembly and enzymatic activity of the Mixed Lineage Leukemia protein-1 core complex
The Mixed Lineage Leukemia protein-1 (MLL1) belongs to the SET1 family of histone H3 lysine 4 methyltransferases. Recent studies indicate that the catalytic subunits of SET1 family members are regulated by interaction with a conserved core group of proteins that include the WD-repeat protein-5 (WDR5), retinoblastoma binding protein-5 (RbBP5), and the Absent small homeotic-2-like protein (Ash2L). It has been suggested that WDR5 functions to bridge the interactions between the catalytic and regulatory subunits of SET1 family complexes. However, the molecular details of these interactions are unknown. To gain insight into the interactions among these proteins we have determined the biophysical basis for the interaction between the human WDR5 and MLL1. Our studies reveal that WDR5 preferentially recognizes a previously unidentified and conserved arginine containing motif- called the “Win” or WDR5 interaction motif, which is located in the N-SET region of MLL1 and other SET1 family members. Surprisingly, our structural and functional studies show that WDR5 recognizes arginine 3765 of the MLL1 Win motif using the same arginine binding pocket on WDR5 that was previously shown to bind histone H3. We demonstrate that WDR5’s recognition of arginine 3765 of MLL1 is essential for the assembly and enzymatic activity of the MLL1 core complex in vitro.
Molecular Mechanism of Sequence-Directed DNA Loading and Translocation by FtsK
Dimeric circular chromosomes, formed by recombination between monomer sisters, cannot be segregated to daughter cells at cell division. XerCD site-specific recombination at the Escherichia coli dif site converts these dimers to monomers in a reaction that requires the DNA translocase FtsK. Short DNA sequences, KOPS (GGGNAGGG), which are polarized toward dif in the chromosome, direct FtsK translocation. FtsK interacts with KOPS through a C-terminal winged helix domain γ. The crystal structure of three FtsKγ domains bound to 8 bp KOPS DNA demonstrates how three γ domains recognize KOPS. Using covalently linked dimers of FtsK, we infer that three γ domains per hexamer are sufficient to recognize KOPS and load FtsK and subsequently activate recombination at dif. During translocation, FtsK fails to recognize an inverted KOPS sequence. Therefore, we propose that KOPS act solely as a loading site for FtsK, resulting in a unidirectionally oriented hexameric motor upon DNA.
Base Sequence and Higher-Order Structure Induce the Complex Excited-State Dynamics in DNA
The high photostability of DNA is commonly attributed to efficient radiationless electronic relaxation processes. We used femtosecond time-resolved fluorescence spectroscopy to reveal that the ensuing dynamics are strongly dependent on base sequence and are also affected by higher-order structure. Excited electronic state lifetimes in dG-doped d(A)20 single-stranded DNA and dG·dC-doped d(A)20·d(T)20 double-stranded DNA decrease sharply with the substitution of only a few bases. In duplexes containing d(AGA)·d(TCT) or d(AG)·d(TC) repeats, deactivation of the fluorescing states occurs on the subpicosecond time scale, but the excited-state lifetimes increase again in extended d(G) runs. The results point at more complex and molecule-specific photodynamics in native DNA than may be evident in simpler model systems.
HARP Is an ATP-Driven Annealing Helicase
DNA-dependent adenosine triphosphatases (ATPases) participate in a broad range of biological processes including transcription, DNA repair, and chromatin dynamics. Mutations in the HepA-related protein (HARP) ATPase are responsible for Schimke immuno-osseous dysplasia (SIOD), but the function of the protein is unknown. We found that HARP is an ATP-dependent annealing helicase that rewinds single-stranded DNA bubbles that are stably bound by replication protein A. Other related ATPases, including the DNA translocase Rad54, did not exhibit annealing helicase activity. Analysis of mutant HARP proteins suggests that SIOD is caused by a deficiency in annealing helicase activity. Moreover, the pleiotropy of HARP mutations is consistent with the function of HARP as an annealing helicase that acts throughout the genome to oppose the action of DNA-unwinding activities in the nucleus.
Scientists Decode Set of Cancer Genes
For the first time, researchers have decoded all the genes of a person with cancer and found a set of mutations that might have caused the disease or aided its progression.Using cells donated by a woman in her 50s who died of leukemia, the scientists sequenced all the DNA from her cancer cells and compared it to the DNA from her own normal, healthy skin cells. Then they zeroed in on 10 mutations that occurred only in the cancer cells, apparently spurring abnormal growth, preventing the cells from suppressing that growth and enabling them to fight off chemotherapy.The findings will not help patients immediately, but researchers say they could lead to new therapies and would almost certainly help doctors make better choices among existing treatments, based on a more detailed genetic picture of each patient’s cancer. Though the research involved leukemia, the same techniques can also be used to study other cancers.“This is the first of many of these whole cancer genomes to be sequenced,” said Richard K. Wilson, director of the Genome Sequencing Center at Washington University in St. Louis and the senior author of the study. “They’ll give us a whole bunch of clues about what’s going on in the DNA when cancer starts to bloom.”The mutations — genetic mistakes — found in this research were not inborn, but developed later in life, like most mutations that cause cancer. (Only 5 percent to 10 percent of all cancers are thought to be hereditary.)The new research, by looking at the entire genome — all the DNA — and aiming to find all the mutations involved in a particular cancer, differs markedly from earlier studies, which have searched fewer genes. The project, which took months and cost $1 million, was made possible by recent advances in technology that have made it easier and cheaper to analyze hundreds of millions of DNA snippets. The study is being published Thursday in the journal Nature.Dr. Wilson said he hoped that in 5 to 20 years, decoding a patient’s cancer genome would consist of dropping a spot of blood onto a chip that slides into a desktop computer and getting back a report that suggests which drugs will work best.Wilson“That’s personalized genomics, personalized medicine in a box,” he said. “It’s holy grail sort of stuff, but I think it’s not out of the realm of possibility.””Until now, Dr. Wilson said, most work on cancer mutations has focused on just a few hundred genes already suspected of being involved in the disease, not the 20,000 or so genes that make up the full human genome.The older approach is useful, Dr. Wilson said, “but if there are genes mutated that you don’t know about or don’t expect, you’ll miss them.”Indeed, 8 of the 10 mutations his group discovered would not have been found with the more traditional approach.A cancer expert not involved with the study, Dr. Steven Nimer, chief of the hematology service at Memorial Sloan-Kettering Cancer Center, called the research a “tour de force” and the report “a wonderful paper.” Dr. Nimer said the whole-genome approach seemed likely to yield important information about other types of cancer as well as leukemia.“It is supporting evidence for the idea that you can’t just go after the things you know about,” Dr. Nimer said.He added, “It would be nice to have this kind information on every patient we treat.”NimeDr. Nimer also predicted that oncologists would quickly want to start looking for these mutations in their patients or in stored samples from former patients, to see if they could help in predicting the course of the disease or selecting treatments.Nimer,Studying cancer genomes has become a major thrust of research. In the past few years the government has spent $100 million dollars for genome studies in lung and ovarian cancers and glioblastoma multiforme, a type of brain tumor. The person who gave her cells for the study at Washington University became not only the first cancer patient, but also the first woman to have her entire genome decoded. Her information will be available only to scientists and not posted publicly, to protect her privacy and that of her family. The only other complete human genomes open to researchers so far have come from men, two scientists known for ego as well as intellect, who ran decoding projects and chose to bare their own DNA to the world: James D. Watson and J. Craig Venter. Their genomes are available for all to inspect.The woman at Washington University had acute myelogenous leukemia, a fast-growing cancer that affects about 13,000 people a year in the United States and kills 8,800. Its cause is not well understood. Like most cancers, it is thought to begin in a single cell, with a mutation that is not present at birth but that occurs later for some unknown reason. Generally, one mutation is not enough to cause cancer; the disease does not develop until other mutations occur.Most of them are just these random events in the universe that add up to something horrible,” said Dr. Timothy J. Ley, a hematologist at Washington University and the director of the study.The researchers chose to study this disease because it is severe and the treatment has not improved in decades.It’s one of the nastiest forms of leukemia,” Dr. Wilson said. “It’s very aggressive. It affects mostly adults, and there’s really no good treatment for it. A very large fraction of the patients eventually will die from their disease.”WilsonBefore starting treatment, the patient they studied had donated samples of bone marrow and skin, so the researchers could compare her normal skin cells to cancer cells from her bone marrow. Some of the patient’s mutated genes appeared to promote cancer growth. One probably made the cancer drug-resistant by enabling the tumor cells to pump chemotherapy drugs right out of the cell before they could do their work. The other mutated genes seemed to be tumor suppressors, the body’s natural defense against dangerous genetic mistakes.Their job is surveillance,” Dr. Wilson said. “If cells start to do something out of control, these genes are there to shut it down. When we find three or four suppressors inactivated, it’s almost like tumor has systematically started to knock out that surveillance mechanism. That makes it tougher to kill. It gets a little freaky. This is unscientific, but we say, gee, it looks like the tumor has a mind of its own, it knows what genes it has to take out to be successful. It’s amazing.”WilsonTests of 187 other patients with acute myelogenous leukemia found that none had the eight new mutations found in the first patient.。That finding suggests that many genetic detours can lead to the same awful destination, and that many more genomes must be studied, but it does not mean that every patient will need his or her own individual drug, Dr. Wilson said.Wilson“Ultimately, one signal tells the cell to grow, grow, grow,” he said. “There has to be something in common. It’s that commonality we’ll find that will tell us what treatment will be the most powerful.”
DNA testing of family .Experts believe that more harm than good
In the United States, there are now many people are keen on their own DNA testing. This test is very simple, only to spend much of the money will be able to know that they may be suffering from some kind of genetic disease risk, but some medical experts on DNA testing that worried about the trend of the spread.
Huolihaji this year, 51-year-old, her mother is an Alzheimer's disease patients, Holly hopes to know whether a genetic test will also suffer from the same disease. So Holly recently spent 2,500 dollars to buy a home DNA test, the statement indicated that the device can detect 19 kinds of suffering from genetic disease risk.
After testing, Holly found himself suffering from Alzheimer's disease is the possibility of 30%. Holly said she felt a better understanding of their own, and now she intends to resign from the sale of the work to become a nurse. The decision, to some extent, DNA testing is done to help her.
However, DNA testing has led to great controversy. Medicine is a family advocate for DNA testing, simple test equipment that can help people find potential disease threats. But scientists do not agree with this practice, first of all, the reliability of test results aside, it is possible the results of those tests would have a negative impact on sentiment; more importantly, DNA testing is likely to trigger a series of medical Ethical issues, such as DNA may be discriminated against, and so on, must be careful.
Huolihaji this year, 51-year-old, her mother is an Alzheimer's disease patients, Holly hopes to know whether a genetic test will also suffer from the same disease. So Holly recently spent 2,500 dollars to buy a home DNA test, the statement indicated that the device can detect 19 kinds of suffering from genetic disease risk.
After testing, Holly found himself suffering from Alzheimer's disease is the possibility of 30%. Holly said she felt a better understanding of their own, and now she intends to resign from the sale of the work to become a nurse. The decision, to some extent, DNA testing is done to help her.
However, DNA testing has led to great controversy. Medicine is a family advocate for DNA testing, simple test equipment that can help people find potential disease threats. But scientists do not agree with this practice, first of all, the reliability of test results aside, it is possible the results of those tests would have a negative impact on sentiment; more importantly, DNA testing is likely to trigger a series of medical Ethical issues, such as DNA may be discriminated against, and so on, must be careful.
Israel plans Buck Beauchamp developed a laboratory animal DNA labeling technology
Israel plans Buck Beauchamp developed a laboratory animal DNA labeling technology, the use of technology can not only determine the identity of the livestock, but also the variety of meat on the market situation and safety testing.
Timbuktu Beacham laboratory Israel is engaged in a food, water, environment and micro-organisms, such as chemical detection laboratory professionals, the technology is to identify the stolen cattle developed. Researchers at birth in cattle that is collecting DNA samples, based on this genetic information to establish the database. Detection, only a small amount of DNA samples collected through computer analysis, to get the animal species, born and reared in such areas.
In recent years, the public response to the concerns of livestock disease, researchers began to apply the technology to cattle and other livestock health and safety testing. The use of DNA database, researchers can determine whether the cow had been tested by the outbreak of mad cow disease, such as infections, may also distinguish whether a mix of milk in the milk and other livestock; of the Jewish people, the use of technology can also be judged Eat beef with the rules provided for in cleanliness standards.
The laboratory of molecular biology expert caja Aviv, said that, at present, subject to a livestock farm, such as foot-and-mouth epidemic after the attack, the approach taken by the normally all likely to be infected livestock slaughtered all out, it is unnecessary . Use of their research and development of DNA labeling technology, can effectively distinguish between the health of livestock, livestock losses to reduce the practical significance. To consumers, the technology can also help them to obtain relevant information, such as by buying beef from the farm which, in what manner to feed, whether or not genuine, and so on, which is to enhance public confidence in meat products would also be useful.
It is said that the laboratory in the near future plan on the establishment of a nationwide cattle DNA database pilot, if successful, Israel will have to become the world's first national DNA database of cattle.
Timbuktu Beacham laboratory Israel is engaged in a food, water, environment and micro-organisms, such as chemical detection laboratory professionals, the technology is to identify the stolen cattle developed. Researchers at birth in cattle that is collecting DNA samples, based on this genetic information to establish the database. Detection, only a small amount of DNA samples collected through computer analysis, to get the animal species, born and reared in such areas.
In recent years, the public response to the concerns of livestock disease, researchers began to apply the technology to cattle and other livestock health and safety testing. The use of DNA database, researchers can determine whether the cow had been tested by the outbreak of mad cow disease, such as infections, may also distinguish whether a mix of milk in the milk and other livestock; of the Jewish people, the use of technology can also be judged Eat beef with the rules provided for in cleanliness standards.
The laboratory of molecular biology expert caja Aviv, said that, at present, subject to a livestock farm, such as foot-and-mouth epidemic after the attack, the approach taken by the normally all likely to be infected livestock slaughtered all out, it is unnecessary . Use of their research and development of DNA labeling technology, can effectively distinguish between the health of livestock, livestock losses to reduce the practical significance. To consumers, the technology can also help them to obtain relevant information, such as by buying beef from the farm which, in what manner to feed, whether or not genuine, and so on, which is to enhance public confidence in meat products would also be useful.
It is said that the laboratory in the near future plan on the establishment of a nationwide cattle DNA database pilot, if successful, Israel will have to become the world's first national DNA database of cattle.
Stepwise chromatin remodelling by a cascade of transcription initiation of non-coding RNAs
Recent transcriptome analyses using high-density tiling arrays1, 2, 3 and data from large-scale analyses of full-length complementary DNA libraries by the FANTOM3 consortium4, 5 demonstrate that many transcripts are non-coding RNAs (ncRNAs). These transcriptome analyses indicate that many of the non-coding regions, previously thought to be functionally inert, are actually transcriptionally active regions with various features. Furthermore, most relatively large (several kilobases) polyadenylated messenger RNA transcripts are transcribed from regions harbouring little coding potential. However, the function of such ncRNAs is mostly unknown and has been a matter of debate2. Here we show that RNA polymerase II (RNAPII) transcription of ncRNAs is required for chromatin remodelling at the fission yeast Schizosaccharomyces pombe fbp1 + locus during transcriptional activation. The chromatin at fbp1 + is progressively converted to an open configuration, as several species of ncRNAs are transcribed through fbp1 +. This is coupled with the translocation of RNAPII through the region upstream of the eventual fbp1 + transcriptional start site. Insertion of a transcription terminator into this upstream region abolishes both the cascade of transcription of ncRNAs and the progressive chromatin alteration. Our results demonstrate that transcription through the promoter region is required to make DNA sequences accessible to transcriptional activators and to RNAPII.
Subscribe to:
Posts (Atom)
